Bromhexine
Specifications
3572-43-8CAS Number
222-684-1EC Number
2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]anilineIUPAC Name
C14H20Br2N2Chemical Formula
376.13 g/molMolecular Weight
bromhexine; 3572-43-8; Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-; Bromhexina; Bromhexinum; Fluibron; 2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline; 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline; Q1J152VB1P; CHEBI:77032; 2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline; DTXSID6022686; NA274; N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine; 3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine; Bromexina; DurElix; bromhexin von ct; Dur Elix; BC, Bromhexin; Bromhexinratiopharm; Bromhexine, Famel; ct, bromhexin von; von ct, bromhexin; Hustentabsratiopharm; Bromhexin ratiopharm; Bromhexin-ratiopharm; Hustentabs ratiopharm; Bromhexin BerlinChemie; Bromhexin Berlin Chemie; Bromhexin Berlin-Chemie; RefChem:5615; DTXCID202686; R05CB02; 222-684-1; Bromexine; Bromhexine [INN:BAN]; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine; Bromhexine (INN); BROMHEXINE [INN]; Toluene-.alpha.,2-diamine, 3,5-dibromo-N.alpha.-cyclohexyl-N.alpha.-methyl-; [(2-amino-3,5-dibromophenyl)methyl]cyclohexylmethylamine; C14H20Br2N2; Bromhexinum [INN-Latin]; Bromhexina [INN-Spanish]; SMR001826324; EINECS 222-684-1; UNII-Q1J152VB1P; Fluibron (TN); MFCD00436295; N-Cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amin; Spectrum_001392; BROMHEXINE [MI]; 3,5-Dibromo-Nalpha-cyclohexyl-Nalpha-methyltoluene-alpha-2-diamine; Spectrum2_001526; Spectrum3_001152; Spectrum4_000758; Spectrum5_001054; BROMHEXINE [MART.]; BROMHEXINE [WHO-DD]; Oprea1_147116; SCHEMBL19059; BSPBio_002703; KBioGR_001116; KBioSS_001872; MLS004774079; MLS006011815; DivK1c_000455; SPBio_001312; CHEMBL253376; orb1704843; SCHEMBL29379593; GTPL11218; KBio1_000455; KBio2_001872; KBio2_004440; KBio2_007008; KBio3_002203; OJGDCBLYJGHCIH-UHFFFAOYSA-; NINDS_000455; HMS2090K17; HMS5085L19; HY-B0372; N-(2-AMINO-3,5-DIBROMOBENZYL)-N-CYCLOHEXYL-N-METHYLAMINE; BDBM50239965; EBC-26845; s5943; SBB021209; STK177356; AKOS000305902; DB09019; IDI1_000455; NCGC00178520-01; NCGC00178520-02; NCGC00178520-05; NCGC00178520-10; DA-51406; ST024771; SBI-0051773.P002; CS-0112836; NS00000021; D07542; EN300-228940; G78185; T22281; AB00053644-02; AB00053644_03; AB00053644_04; F905242; Q239778; BRD-K47631482-003-02-1; BRD-K47631482-003-03-9; BRD-K47631482-003-06-2; BRD-K47631482-003-07-0; F2173-0412; 2,4-Dibromo-6-([cyclohexyl(methyl)amino]methyl)aniline #; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemathanamine; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methyl benzenemethanamine; Bromexine; Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-; Toluene-a,2-diamine, 3,5-dibromo-Na-cyclohexyl-Na-methyl- (8CI); 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine; 2,4-Dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline; 2-Amino-3; InChI=1/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3Synonyms
